3 ms·
"I appreciate the videos, but I'm really looking for controlled studies." Here is the first of probably many controlled studies with 2-bromo-LSD for cluster he
by Alex3917 15y ago
"I appreciate the videos, but I'm really looking for controlled studies."
Here is the first of probably many controlled studies with 2-bromo-LSD for cluster headaches:
http://news.sciencemag.org/sciencenow/2011/06/lsd-alleviates-suicide-headaches.html http://news.sciencemag.org/sciencenow/2011/06/lsd-alleviates...
The MDMA research on PTSD also has placebo controls. There are several different studies on this, you can probably find them via maps.org.
And James Fadiman writes about actual research done on problem solving in his book, although it isn't really possible to control since each person's long-standing problem is different.
- jessriedel 15y agoAwesome, thanks! > Cluster headache attack cessation and remission extension of months or longer in six treatment-refractory patients administered only 3 doses of BOL-148 > Five male patients with treatment-refractory chronic cluster headache and one female patient with treatment-refractory mixed cluster/migrainous headache were administered 2-bromo-LSD (BOL-148) (20mcg/kg) at five-day intervals for a total of three treatments. Sixteen-week outcome data on the five male patients revealed a robust treatment response, with three of the five having no attacks for more than one month, thereby shifting their diagnosis back to the episodic form of cluster headache. Similarly, the female patient reported quiescence of cluster attacks for greater than one month and "significant" improvement in migraine in the following weeks from last dose of BOL-148. This poster presents longterm outcome data on all 6 patients who received BOL-148. In follow-up with these patients, BOL-148 provided significant headache relief that lasted for several months to more than one-year. Data suggests that BOL-148 may function as an important new treatment, though, at present, there is no explanation for such long-term prophylactic effects with no later drug re-administrations. There is some evidence that BOL-148 is affecting epigenetic mechanisms and may open the possibility for a near-cure-like treatment for patients afflicted with vascular headaches. Incidentally, this is apparently a non-hallucinogenic analog of LSD.